Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. | Tris Pharma has pointed to a phase 3 win for its pain ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with a substantial market capitalization of $110.13 billion, continues to ...
Ogo Egbuna works at Vertex leading the company’s precision medicine kidney programs in APOL1-mediated and Polycystic kidney ...